医療レポート：Postherpetic Neuralgia-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
3 Epidemiology 8
3.1 Disease Overview 8
3.2 Risk Factors and Comorbidities 9
3.2.1 Elderly herpes zoster patients are almost 20 times more likely to develop PHN 9
3.2.2 Herpes zoster vaccine reduces the morbidity of herpes zoster and PHN 11
3.3 Global Trends 11
3.3.1 US 12
3.3.2 France 13
3.3.3 Germany 14
3.3.4 Italy 14
3.3.5 Spain 15
3.3.6 UK 16
3.3.7 Japan 17
3.4 Forecast Metodology 17
3.4.1 Sources Used 19
3.4.2 Forecast Assumptions and Methods 22
3.4.3 Sources Not Used 26
3.5 Epidemiological Forecast of Postherpetic Neuralgia (2012–2022) 27
3.5.1 Incident Cases of PHN 27
3.5.2 Age-Specific Incident Cases of PHN 28
3.5.3 Sex-Specific Incident Cases of PHN 30
3.5.4 Age-Standardized Incidence of PHN 32
3.6 Discussion 33
3.6.1 Epidemiological Forecast Insight 33
3.6.2 Limitations of the Analysis 34
3.6.3 Strengths of the Analysis 35
4 Appendix 37
4.1 Bibliography 37
4.2 About the Authors 40
4.2.1 Epidemiologists 40
4.2.2 Reviewers 40
4.2.3 Franka des Vignes, PhD, Global Director of Epidemiology and Health Policy 42
4.2.4 Bonnie Bain, PhD, Global Head of Healthcare 42
4.3 About GlobalData 43
4.4 About EpiCast 43
4.5 Disclaimer 44